ACTRN12619001616167已完成4 期
Effect of Trimetazidine on clinical events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
Hamlet Hayrapetyan, FESC0 个研究点目标入组 680 人开始时间: 2019年11月22日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 680
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •ST-elevation myocardial infarction
排除标准
- •previous or recurrent acute myocardial infarction, heart valve disease, acute cerebrovascular or vessel disease, serious renal or live failure, oncologic disease or any other non-cardiologic serious medical condition with a life expectancy of less than 1 year,
研究者
相似试验
尚未招募
3 期
Investigation of the effect of Trimetazidine in patients with Aluminum phosphide poisoningIRCT20211017052794N1Shahid Beheshti University of Medical Sciences30
进行中（未招募）
1 期
Efficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.Patients with Angina pectoris having been treated by Percutaneous Coronary InterventionMedDRA version: 16.1Level: PTClassification code 10002383Term: Angina pectorisSystem Organ Class: 10007541 - Cardiac disordersEUCTR2010-022134-89-GRI.R.I.S.10,300
进行中（未招募）
1 期
Efficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.EUCTR2010-022134-89-LVI.R.I.S.10,300
撤回
3 期
The efficAcy and safety of Trimetazidine in Patients with angina pectoris having been treated by percutaneous Coronary Intervention. ATPCI study An international, multicentre, randomised, double-blind, placebo-controlled study in patients treated for 2 to 4 years.chest painspasm of the heart10011082NL-OMON38975Servier200
进行中（未招募）
不适用
Efficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.EUCTR2010-022134-89-EEI.R.I.S.10,300